Re: exciting preclinical finding re metformin (diabetes drug) killing cancer stem cel
the money will probably need to come from Susan Komen or some other source not trying to sell a drug (metformin has been on the market for years so it must by now be off patent and available as a generic) and it usually costs quite a bit of money to pay for the time of the doctors, nurses, statisticians, etc
The same problem comes up with trials of accelerated breast irradiation and other new treatments for which no device or drug company will come up with the money.
|